Abbott Labs punctuated the August doldrums today with this SEC filing describing a plan to “streamline global manufacturing operations.” That turns out to be code for closing a manufacturing plant and cutting jobs, Dow Jones Newswires reports.
The plant, in South Pasadena, Calif., is part of the company’s diagnostics business and will close some time in [...]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment